This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Feb;18(2):95-110.

doi: 10.1021/tx049847p.

Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen

John R Jalas¹, Stephen S Hecht, Sharon E Murphy

Affiliations

PMID: 15720112
DOI: 10.1021/tx049847p

Review

Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen

John R Jalas et al. Chem Res Toxicol. 2005 Feb.

. 2005 Feb;18(2):95-110.

doi: 10.1021/tx049847p.

Authors

John R Jalas¹, Stephen S Hecht, Sharon E Murphy

Affiliation

¹ Department of Chemistry, University of Minnesota, 207 Pleasant Street SE, Minneapolis, Minnesota 55455, USA.

PMID: 15720112
DOI: 10.1021/tx049847p

No abstract available

PubMed Disclaimer

Similar articles

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ, Guo Z, Gonzalez FJ, Guengerich FP, Stoner GD, Yang CS. Smith TJ, et al. Cancer Res. 1992 Apr 1;52(7):1757-63. Cancer Res. 1992. PMID: 1312898
Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
Staretz ME, Murphy SE, Patten CJ, Nunes MG, Koehl W, Amin S, Koenig LA, Guengerich FP, Hecht SS. Staretz ME, et al. Drug Metab Dispos. 1997 Feb;25(2):154-62. Drug Metab Dispos. 1997. PMID: 9029045
Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.
Smith TJ, Stoner GD, Yang CS. Smith TJ, et al. Cancer Res. 1995 Dec 1;55(23):5566-73. Cancer Res. 1995. PMID: 7585636
Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen.
Hecht SS. Hecht SS. Crit Rev Toxicol. 1996;26(2):163-81. doi: 10.3109/10408449609017929. Crit Rev Toxicol. 1996. PMID: 8688159 Review.
DNA and hemoglobin adducts as markers of metabolic activation of tobacco-specific carcinogens.
Foiles PG, Murphy SE, Peterson LA, Carmella SG, Hecht SS. Foiles PG, et al. Cancer Res. 1992 May 1;52(9 Suppl):2698s-2701s. Cancer Res. 1992. PMID: 1563001 Review.

See all similar articles

Cited by

Identification of an N'-Nitrosonornicotine-Specific Deoxyadenosine Adduct in Rat Liver and Lung DNA.
Li Y, Hecht SS. Li Y, et al. Chem Res Toxicol. 2021 Apr 19;34(4):992-1003. doi: 10.1021/acs.chemrestox.1c00013. Epub 2021 Mar 11. Chem Res Toxicol. 2021. PMID: 33705110 Free PMC article.
Metabolism and DNA Adduct Formation of Tobacco-Specific N-Nitrosamines.
Li Y, Hecht SS. Li Y, et al. Int J Mol Sci. 2022 May 4;23(9):5109. doi: 10.3390/ijms23095109. Int J Mol Sci. 2022. PMID: 35563500 Free PMC article. Review.
Multifunctional Activity-Based Protein Profiling of the Developing Lung.
Stoddard EG, Volk RF, Carson JP, Ljungberg CM, Murphree TA, Smith JN, Sadler NC, Shukla AK, Ansong C, Wright AT. Stoddard EG, et al. J Proteome Res. 2018 Aug 3;17(8):2623-2634. doi: 10.1021/acs.jproteome.8b00086. Epub 2018 Jul 18. J Proteome Res. 2018. PMID: 29972024 Free PMC article.
Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis.
Wassenaar CA, Dong Q, Amos CI, Spitz MR, Tyndale RF. Wassenaar CA, et al. Int J Mol Sci. 2013 Apr 16;14(4):8381-92. doi: 10.3390/ijms14048381. Int J Mol Sci. 2013. PMID: 23591849 Free PMC article.
Interactions of Betel Quid Constituents with Drug Disposition Pathways: An Overview.
Canlas J, Myers AL. Canlas J, et al. Curr Drug Metab. 2023;24(2):92-105. doi: 10.2174/1389200224666230228142052. Curr Drug Metab. 2023. PMID: 36852799 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- American Chemical Society